vs

Side-by-side financial comparison of OP Bancorp (OPBK) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $24.3M, roughly 1.5× OP Bancorp). On growth, OP Bancorp posted the faster year-over-year revenue change (13.7% vs -57.1%). Over the past eight quarters, OP Bancorp's revenue compounded faster (11.4% CAGR vs -46.5%).

OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

OPBK vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.5× larger
ORGO
$37.2M
$24.3M
OPBK
Growing faster (revenue YoY)
OPBK
OPBK
+70.8% gap
OPBK
13.7%
-57.1%
ORGO
Faster 2-yr revenue CAGR
OPBK
OPBK
Annualised
OPBK
11.4%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPBK
OPBK
ORGO
ORGO
Revenue
$24.3M
$37.2M
Net Profit
Gross Margin
30.8%
Operating Margin
39.2%
-185.1%
Net Margin
Revenue YoY
13.7%
-57.1%
Net Profit YoY
EPS (diluted)
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPBK
OPBK
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$24.3M
$225.6M
Q3 25
$24.5M
$150.9M
Q2 25
$23.7M
$101.0M
Q1 25
$22.2M
$86.7M
Q4 24
$21.3M
$126.7M
Q3 24
$20.7M
$115.2M
Q2 24
$20.4M
$130.2M
Net Profit
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$6.7M
$21.6M
Q2 25
$6.3M
$-9.4M
Q1 25
$5.6M
$-18.8M
Q4 24
$7.7M
Q3 24
$5.4M
$12.3M
Q2 24
$5.4M
$-17.0M
Gross Margin
OPBK
OPBK
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
OPBK
OPBK
ORGO
ORGO
Q1 26
-185.1%
Q4 25
39.2%
28.1%
Q3 25
39.5%
13.7%
Q2 25
35.7%
-12.5%
Q1 25
34.6%
-30.9%
Q4 24
31.2%
8.1%
Q3 24
36.5%
5.4%
Q2 24
37.2%
-10.7%
Net Margin
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
27.4%
14.3%
Q2 25
26.7%
-9.3%
Q1 25
25.0%
-21.7%
Q4 24
6.1%
Q3 24
26.2%
10.7%
Q2 24
26.7%
-13.1%
EPS (diluted)
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
$0.48
$0.31
Q3 25
$0.45
$0.11
Q2 25
$0.42
$-0.10
Q1 25
$0.37
$-0.17
Q4 24
$0.33
$0.05
Q3 24
$0.36
$0.09
Q2 24
$0.36
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPBK
OPBK
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$167.3M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$227.9M
Total Assets
$2.7B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPBK
OPBK
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$167.3M
$93.7M
Q3 25
$166.7M
$63.7M
Q2 25
$205.4M
$73.1M
Q1 25
$198.9M
$110.0M
Q4 24
$134.9M
$135.6M
Q3 24
$166.8M
$94.3M
Q2 24
$127.7M
$89.9M
Total Debt
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
$227.9M
$300.1M
Q3 25
$221.5M
$255.1M
Q2 25
$213.7M
$233.2M
Q1 25
$210.1M
$242.9M
Q4 24
$205.0M
$262.9M
Q3 24
$203.6M
$278.5M
Q2 24
$195.9M
$263.5M
Total Assets
OPBK
OPBK
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$2.7B
$598.7M
Q3 25
$2.6B
$509.8M
Q2 25
$2.6B
$461.1M
Q1 25
$2.5B
$467.4M
Q4 24
$2.4B
$497.9M
Q3 24
$2.4B
$446.3M
Q2 24
$2.3B
$443.2M
Debt / Equity
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPBK
OPBK
ORGO
ORGO
Operating Cash FlowLast quarter
$26.2M
Free Cash FlowOCF − Capex
$23.4M
FCF MarginFCF / Revenue
96.2%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
$26.2M
$39.4M
Q3 25
$23.9M
$3.1M
Q2 25
$-7.0M
$-32.9M
Q1 25
$5.6M
$-19.9M
Q4 24
$31.2M
$10.9M
Q3 24
$13.3M
$8.7M
Q2 24
$15.8M
$4.7M
Free Cash Flow
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
$23.4M
$34.8M
Q3 25
$23.4M
$844.0K
Q2 25
$-7.7M
$-36.5M
Q1 25
$4.2M
$-23.6M
Q4 24
$29.7M
$7.6M
Q3 24
$12.8M
$6.1M
Q2 24
$15.7M
$2.9M
FCF Margin
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
96.2%
15.4%
Q3 25
95.6%
0.6%
Q2 25
-32.5%
-36.1%
Q1 25
19.0%
-27.2%
Q4 24
139.0%
6.0%
Q3 24
61.5%
5.3%
Q2 24
77.0%
2.2%
Capex Intensity
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
11.5%
2.1%
Q3 25
2.3%
1.5%
Q2 25
3.0%
3.6%
Q1 25
6.4%
4.2%
Q4 24
7.3%
2.7%
Q3 24
2.8%
2.2%
Q2 24
0.4%
1.4%
Cash Conversion
OPBK
OPBK
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
3.57×
0.14×
Q2 25
-1.10×
Q1 25
1.02×
Q4 24
1.43×
Q3 24
2.45×
0.71×
Q2 24
2.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons